343 related articles for article (PubMed ID: 12773526)
1. Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.
Blixt O; Collins BE; van den Nieuwenhof IM; Crocker PR; Paulson JC
J Biol Chem; 2003 Aug; 278(33):31007-19. PubMed ID: 12773526
[TBL] [Abstract][Full Text] [Related]
2. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
4. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
Kelm S; Pelz A; Schauer R; Filbin MT; Tang S; de Bellard ME; Schnaar RL; Mahoney JA; Hartnell A; Bradfield P
Curr Biol; 1994 Nov; 4(11):965-72. PubMed ID: 7533044
[TBL] [Abstract][Full Text] [Related]
5. Ligands for siglecs.
Kelm S
Results Probl Cell Differ; 2001; 33():153-76. PubMed ID: 11190673
[No Abstract] [Full Text] [Related]
6. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
[TBL] [Abstract][Full Text] [Related]
7. High-affinity ligands of Siglec receptors and their therapeutic potentials.
Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
[TBL] [Abstract][Full Text] [Related]
8. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
Jones C; Virji M; Crocker PR
Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
[TBL] [Abstract][Full Text] [Related]
9. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
Sgroi D; Nocks A; Stamenkovic I
J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
[TBL] [Abstract][Full Text] [Related]
10. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9.
Yamaji T; Teranishi T; Alphey MS; Crocker PR; Hashimoto Y
J Biol Chem; 2002 Feb; 277(8):6324-32. PubMed ID: 11741958
[TBL] [Abstract][Full Text] [Related]
11. Sialic acid binding receptors (siglecs) expressed by macrophages.
Munday J; Floyd H; Crocker PR
J Leukoc Biol; 1999 Nov; 66(5):705-11. PubMed ID: 10577497
[TBL] [Abstract][Full Text] [Related]
12. The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.
Kelm S; Schauer R; Crocker PR
Glycoconj J; 1996 Dec; 13(6):913-26. PubMed ID: 8981082
[TBL] [Abstract][Full Text] [Related]
13. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.
Nath D; van der Merwe PA; Kelm S; Bradfield P; Crocker PR
J Biol Chem; 1995 Nov; 270(44):26184-91. PubMed ID: 7592823
[TBL] [Abstract][Full Text] [Related]
14. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
15. Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E.
Redelinghuys P; Antonopoulos A; Liu Y; Campanero-Rhodes MA; McKenzie E; Haslam SM; Dell A; Feizi T; Crocker PR
J Biol Chem; 2011 Oct; 286(40):34522-32. PubMed ID: 21835922
[TBL] [Abstract][Full Text] [Related]
16. Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin.
Zaccai NR; Maenaka K; Maenaka T; Crocker PR; Brossmer R; Kelm S; Jones EY
Structure; 2003 May; 11(5):557-67. PubMed ID: 12737821
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
18. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
19. Basic and clinical immunology of Siglecs.
von Gunten S; Bochner BS
Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules.
Freeman SD; Kelm S; Barber EK; Crocker PR
Blood; 1995 Apr; 85(8):2005-12. PubMed ID: 7718872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
